Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hair loss is caused by diet, hormones, and scalp issues, worsened by COVID-19, with treatments like minoxidil and hair transplants available.

Hair loss is caused by nutritional deficiencies, hormonal imbalances, and stress, with treatments like minoxidil and hair transplants available.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

High LH levels cause hair loss by damaging and aging hair follicles.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

Women aged 21-26 have a higher rate of PCOS.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.